This PPG is organized to perform basic research which is oriented towards understanding fundamental mechanisms underlying renal stone formation. Project 1 will explore the contributions of cell injury a) to calcium oxalate (CaOx) urolithiasis by studying the reactions of renal tissue culture cells exposed to CaOx crystals and/or oxalate (Ox) ion, and b) to retention of CaOx crystals at the renal papillary tip in a rat model. In both systems, anti-oxidized agents will be employed to test the hypothesis that modifying cell injury will interrupt the crystallization urolithiasis processes. Project 2 will develop a better understanding of the relationship between phosphate and Ox by investigating the concept that calcium phosphate is a nucleator for CaOx. It is proposed that phosphate nidi produced in the rat using a well-defined diet will subsequently act as nucleators for CaOx calculi. The role of bacterial membranes in stone formation will be studied by characterizing non-urease producing bacteria from stone patients; bacterial mineralization will be examined in a rat model in vivo. Project 3 will evaluate the role of several aggregation mechanisms in stone disease. Interparticle bond strength will be determined in model systems by determining the hydrodynamic stress required to displace aggregates in suspension and particles attached to surfaces. Theoretical predictions will evaluate the interparticle strength of each aggregation mechanism. Project 4 will study nucleation and growth of CaOx monohydrate and further expand knowledge of enthalpy and entropy of activation. Temperature dependence of nucleation kinetics will be analyzed and the role of desolvation in nuclei organization will be determined. The hypothesis that transfer of phosphatidylserine from the cytoplasmic face of the outer cell membrane to the exoplasmic face plays a role in crystalluria from cell damage will be tested. The scope of EQUIL software will be extended to create a method for analyzing CaOx supersaturation in human serum. Core A will provide analytical support including chemical analysis of urine for various ions and molecules, and will provide data for determination of relative supersaturation. Electron microscopy will also be centralized in this Core. Core B will provide budget administration for the entire PPG and other services such as preparation of travel documents, editorial review of manuscripts and production of reports.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Program Projects (P01)
Project #
2P01DK020586-16
Application #
3095224
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Project Start
1977-09-01
Project End
1997-08-31
Budget Start
1992-09-01
Budget End
1993-08-31
Support Year
16
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Florida
Department
Type
Schools of Medicine
DUNS #
073130411
City
Gainesville
State
FL
Country
United States
Zip Code
32611
Atmani, F; Khan, S R (1999) Role of inter-alpha-inhibitor and its related proteins in urolithiasis. Purification of an inter-alpha-inhibitor related protein from the bovine kidney. Urol Res 27:57-61
Atmani, F; Glenton, P A; Khan, S R (1999) Role of inter-alpha-inhibitor and its related proteins in experimentally induced calcium oxalate urolithiasis. Localization of proteins and expression of bikunin gene in the rat kidney. Urol Res 27:63-7
Sidhu, H; Schmidt, M E; Cornelius, J G et al. (1999) Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy. J Am Soc Nephrol 10 Suppl 14:S334-40
Thamilselvan, S; Hackett, R L; Khan, S R (1999) Cells of proximal and distal tubular origin respond differently to challenges of oxalate and calcium oxalate crystals. J Am Soc Nephrol 10 Suppl 14:S452-6
Iida, S; Peck, A B; Johnson-Tardieu, J et al. (1999) Temporal changes in mRNA expression for bikunin in the kidneys of rats during calcium oxalate nephrolithiasis. J Am Soc Nephrol 10:986-96
Sidhu, H; Holmes, R P; Allison, M J et al. (1999) Direct quantification of the enteric bacterium Oxalobacter formigenes in human fecal samples by quantitative competitive-template PCR. J Clin Microbiol 37:1503-9
Thamilselvan, S; Khan, S R (1998) Oxalate and calcium oxalate crystals are injurious to renal epithelial cells: results of in vivo and in vitro studies. J Nephrol 11 Suppl 1:66-9
Atmani, F; Glenton, P A; Khan, S R (1998) Identification of proteins extracted from calcium oxalate and calcium phosphate crystals induced in the urine of healthy and stone forming subjects. Urol Res 26:201-7
Sidhu, H; Allison, M; Peck, A B (1997) Identification and classification of Oxalobacter formigenes strains by using oligonucleotide probes and primers. J Clin Microbiol 35:350-3
Khan, S R (1997) Animal models of kidney stone formation: an analysis. World J Urol 15:236-43

Showing the most recent 10 out of 51 publications